[1] Goldring M, Berenbaum F. Emerging targets in osteoarthritis therapy. Curr Opin Pharmacol. 2015;2022:51-63.[2] Tew S, McDermott B, Fentem R, et al. Transcriptome-wide analysis of messenger RNA decay innormal and osteoarthritic human articular chondrocytes. Arthritis Rheumatol. 2014; 2066(2011):3052-3061.[3] Cai D, Yin S, Yang J, et al. Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. Arthritis Res Ther.2015; 2017:2269.[4] Davidson RK, Jupp O, de Ferrars R, et al. Sulforaphane represses matrix-degrading proteases and protects cartilage from destruction in vitro and in vivo. Arthritis Rheum.2013; 2065:3130-3140.[5] 徐会勇. TGF-β_1与BMP-2对髁突软骨细胞Ⅱ型胶原及蛋白多糖合成的影响[D].昆明医学院, 2007.[6] Appleton C, Usmani S, Pest M, et al. Reduction in disease progression by inhibition of transforminggrowth factor alpha-CCL2 signaling in experimental posttraumatic osteoarthritis. Arthritis Rheumatol. 2015;2067:2691-2701.[7] Lees S, Golub SB, Last K, et al. Bioactivity in an aggrecan 32-mer ragment ismediated via toll-like receptor. Arthritis Rheumatol.2015;2067:1240-1249.[8] [Adouni M, Shirazi AA. Partitioning of knee joint internalforces in gait is dictated by the knee adduction angle and notby the knee adduction moment. J Biomech. 2014;2047:1696-2703.[9] Ateshian G, Henak C, Weiss J. Toward patient- specificarticular contact mechanics. J Biomech 2015;2048: 2779-2086.[10] Henak C, Abraham C, Anderson A, et al. Patient-specific analysis of cartilage and labrum mechanics in human hips with acetabular dysplasia. Osteoarthritis Cartilage. 2014; 2022:2210-2017.[11] Chehab E, Favre J, Erhart-Hledik J, et al. Baseline knee adduction and flexion moments during walking are both associated with 5 year cartilage changes in patients with medial knee osteoarthritis. Osteoarthritis Cartilage.2014; 2022:1833-1839.[12] Moore AC, Burris DL.Tribological and material properties for cartilage of and throughout the bovine stifle: support for the altered joint kinematics hypothesis of osteoarthritis. Osteoarthritis Cartilage. 2015;23(1):161-169. [13] Wang H, Chen T, Torzilli P, et al. Dynamic contact stress patterns on the tibial plateaus during simulated gait: a novel application of normalized cross correlation. J Biomech.2014; 2047:2568-2074.[14] Walker P, Arno S, Bell C, et al. Function of the medial meniscus in force transmission and stability.J Biomech.2015; 2048:1383-1388.[15] Fischenich K, Coatney G, Haverkamp J, et al. Evaluation of meniscal mechanics and proteoglycan content in a modified anterior cruciate ligament transection model. J Biomech Eng. 2014;2136:2011-2018.[16] Gannon A, Nagel T, Bell A, et al. The changing role of the superficial region in determining the dynamic compressive properties of articular cartilage during postnatal development. Osteoarthritis Cartilage 2015;2023:975-984.[17] Stoppiello L, Mapp P, Wilson D, et al. Structural associations of symptomatic knee osteoarthritis. Arthritis Rheumatol.2014; 2066(2011):3018-2027.[18] Pecchi E, Priam S, Gosset M, et al.Induction of nerve growth factor expression and release by mechanical and in?ammatory stimuli in chondrocytes:possible involvement in osteoarthritis pain. Arthritis Res Ther.2014;2016(2011):R2016.[19] Blaney Davidson EN, van Caam AP, Vitters EL, et al. TGF-beta is a potent inducer of nerve growth factor in articular cartilage via the ALK5-Smad2/3 pathway Potential role in OA related pain? Osteoarthritis Cartilage. Osteoarthritis Cartilage. 2015;23(3):478-486. [20] Ishikawa G, Koya Y, Tanaka H, et al. Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis. Osteoarthritis Cartilage: 2015; 2023(2016):925-932.[21] Bullock C, Wookey P, Bennett A, et al. Peripheral calcitonin gene-related peptide receptoractivation and mechanical sensitization of the joint in ratmodels of osteoarthritis pain. Arthritis Rheumatol.2014;2066(2018):2188-2200.[22] Benschop R, Collins E, Darling R, et al. Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis related pain. Osteoarthritis Cartilage.2014;2022(2014):578-585.[23] Rahman W, Dickenson A. Emerging targets and therapeutic approaches for the treatment of osteoarthritis pain. Curr Opin Support Palliat Care. 2015;2019(2012):124-130.[24] Kwok J, Grogan S, Meckes B, et al. Atomic force microscopy reveals age-dependent changes in nanomechanical properties of the extracellular matrix of native human menisci:implications for joint degeneration and osteoarthritis. Nanomedicine Nanotechnol Biol Med. 2014;2010:1777-1785.[25] Li Q, Doyran B, Gamer L W, et al. Biomechanical properties of murine meniscus surface via AFM-based nanoindentation. J Biomech.2015;2048:1364-1370.[26] Nguyen T, Oloyede A, Singh S, et al. Microscale consolidation analysis of relaxation behavior of single living chondrocytes subjected to varying strain-rates. J Mech Behav Biomed Mater. 2015;2049:2343-2354.[27] Lee B, Han L, Frank E, et al. Dynamic nanomechanics of individual bone marrow stromal cells and cell-matrix composites during chondrogenic differentiation. J Biomech. 2015;2048:171-175.[28] Lee W, Leddy H, Chen Y, et al. Synergy between Piezo1 and Piezo2 channels confers high-strain mechanosensitivity to articular cartilage. Proc NatlAcad Sci.2014;2111:E5114-2022.[29] Zhang W, Nuki G, Moskowitz R, et al. OARSI recommendations for the management of hip and knee osteoarthritis: Part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage.2010;2018:476-499.[30] Bennell K, Wrigley T, Hunt M, et al.Update on the role of muscle in the genesis and management of knee osteoarthritis. Rheum Dis Clin North Am. 2013;2039:145-176.[31] Messier S, Mihalko S, Legault C, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013; 2310:1263-1273.[32] Laslett L, Kingsbury S, Hensor E, et al. Effect of bisphosphonate use in patients with symptomaticand radiographic knee osteoarthritis: data from the Osteoarthritis Initiative. Ann Rheum Dis. 2014;2073:824-830.[33] Chou R, McDonagh M, Nakamoto E, et al. Analgesics for osteoarthritis: an update of the 2006 comparative effectiveness review. Comparative Effectiveness Reviews.No. 38. Report No. 11-eHC076-EF. Rockville (MD). Agency for Healthcare Research and Quality (US): 2011.[34] Bannuru R, Dasi U, McAlindon T. Reassessing the role of acetaminophen in osteoarthritis: systematic review and meta-analysis. Osteoarthritis Cartilage 2010;2018 Suppl 2012:S2250.[35] Conaghan P, Dickson J, Bolten W, et al. A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis. Rheumatology (Oxford) 2013;2052:1303-1312.[36] Peniston J, Gold M, Wieman M, et al. Longterm tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities. Clin Interv Aging.2012;2017: 517-523.[37] Rutjes AW, Jüni P, da Costa BR, et al. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med: 2012;2157:180-191.[38] Chappell A, Desaiah D, Liu-Seifert H, et al.A double-blind, randomized, placebo controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract 2011;2011:33-41.[39] Clegg D, Reda D, Harris C, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.N Engl J Med: 2006;2354:795-808.[40] Fransen M, Agaliotis M, Nairn L, et al. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomized placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis 2015;2074:851-888.[41] Hill C, Jones G, Lester S, et al. Effect of fish oil on structural progression in knee osteoarthritis: a two year randomized, double-blind clinical trial comparing high dose with low dose. Arthritis Rheum.2013;2065 Suppl 2010:S2914.[42] Abrahamsen B, Grove E, Vestergaard P, et al. registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate. Osteoporos Int. 2014;2025:757-762.[43] Mobashen A. The future of osteoarthritis therapeutics emerging biological therapy. Curr Rheumatol Rep.2013; 2015:385.[44] 荆立忠,潘登,杨久山. 膝骨关节炎非全膝置换手术治疗研究进展[J]. 山东医药, 2016, 56(10):105-106.[45] 陶源,徐祖健,李忠. 膝骨关节炎关节镜治疗概况[J]. 中医正骨, 2010,22(12): 41-43.[46] 王飞,陈竞清,百成,等. 胫骨高位截骨术治疗膝内翻伴膝外摆步态的疗效与不足[J].中国矫形外科杂志, 2006, 14(5): 343-345. |